Advancing imaging biomarker development and translation through the National Cancer Imaging Translational Accelerator (NCITA)
It is estimated that someone is diagnosed with cancer every two minutes in the UK. Clinical imaging offers a minimally invasive way of diagnosing and managing a variety of cancers. The National Cancer Imaging Translational Accelerator (NCITA) consortium now provides researchers with the infrastructu...
المؤلفون الرئيسيون: | , |
---|---|
التنسيق: | Internet publication |
اللغة: | English |
منشور في: |
Research Outreach
2022
|
_version_ | 1826312587895111680 |
---|---|
author | McAteer, M Higgins, G |
author_facet | McAteer, M Higgins, G |
author_sort | McAteer, M |
collection | OXFORD |
description | It is estimated that someone is diagnosed with cancer every two minutes in the UK. Clinical imaging offers a minimally invasive way of diagnosing and managing a variety of cancers. The National Cancer Imaging Translational Accelerator (NCITA) consortium now provides researchers with the infrastructure to conduct high-quality, multi-centre clinical research in the quest to develop standardised imaging biomarkers and accelerate their translation into clinical use. The NCITA consortium and collaborators aim to improve clinical outcomes for patients through early cancer identification and new treatment discoveries. |
first_indexed | 2024-03-07T03:46:47Z |
format | Internet publication |
id | oxford-uuid:bfbfe00b-58cd-45e6-a8a3-db5d19c4f497 |
institution | University of Oxford |
language | English |
last_indexed | 2024-04-09T03:57:05Z |
publishDate | 2022 |
publisher | Research Outreach |
record_format | dspace |
spelling | oxford-uuid:bfbfe00b-58cd-45e6-a8a3-db5d19c4f4972024-03-21T14:46:32ZAdvancing imaging biomarker development and translation through the National Cancer Imaging Translational Accelerator (NCITA)Internet publicationhttp://purl.org/coar/resource_type/c_7ad9uuid:bfbfe00b-58cd-45e6-a8a3-db5d19c4f497EnglishSymplectic ElementsResearch Outreach2022McAteer, MHiggins, GIt is estimated that someone is diagnosed with cancer every two minutes in the UK. Clinical imaging offers a minimally invasive way of diagnosing and managing a variety of cancers. The National Cancer Imaging Translational Accelerator (NCITA) consortium now provides researchers with the infrastructure to conduct high-quality, multi-centre clinical research in the quest to develop standardised imaging biomarkers and accelerate their translation into clinical use. The NCITA consortium and collaborators aim to improve clinical outcomes for patients through early cancer identification and new treatment discoveries. |
spellingShingle | McAteer, M Higgins, G Advancing imaging biomarker development and translation through the National Cancer Imaging Translational Accelerator (NCITA) |
title | Advancing imaging biomarker development and translation through the National Cancer Imaging Translational Accelerator (NCITA) |
title_full | Advancing imaging biomarker development and translation through the National Cancer Imaging Translational Accelerator (NCITA) |
title_fullStr | Advancing imaging biomarker development and translation through the National Cancer Imaging Translational Accelerator (NCITA) |
title_full_unstemmed | Advancing imaging biomarker development and translation through the National Cancer Imaging Translational Accelerator (NCITA) |
title_short | Advancing imaging biomarker development and translation through the National Cancer Imaging Translational Accelerator (NCITA) |
title_sort | advancing imaging biomarker development and translation through the national cancer imaging translational accelerator ncita |
work_keys_str_mv | AT mcateerm advancingimagingbiomarkerdevelopmentandtranslationthroughthenationalcancerimagingtranslationalacceleratorncita AT higginsg advancingimagingbiomarkerdevelopmentandtranslationthroughthenationalcancerimagingtranslationalacceleratorncita |